Topic List : Cardiovascular Health
Heart recipient who gave birth looks back
Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.
Stanford, Apple describe heart-rhythm study
Over 400,000 people have enrolled in a study being conducted by researchers at Stanford and Apple to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.
Heart pump for a young patient
Lizneidy Serratos, a patient at Lucile Packard Children’s Hospital Stanford, became the smallest person in the country to receive a HeartMate 3 ventricular assist device.
Mutations point to possible drug targets
Genetic data from nearly 300,000 patients has helped scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, according to a new study.
Height may contribute to varicose veins
In the largest genetic study of varicose veins ever completed, Stanford researchers and their collaborators provide evidence that being tall is a risk factor for the condition.
Stunted telomeres found in heart disease
Patients with cardiomyopathy have abnormally short telomeres in the cells responsible for heart contraction, Stanford researchers find. This disease hallmark opens new pathways for drug discovery.
Study solves mystery of genetic mutation
Stanford researchers used genetic-editing tools and stem cell technology to uncover whether a genetic mutation linked to a heart rhythm disorder was benign or pathogenic.
Grant awarded to study heart disorder
The American Heart Association awarded Stanford researchers $5 million to develop decision-making tools for patients with atrial fibrillation.
Fitness lowers genetic risk of heart disease
In an observational study of almost a half-million participants, Stanford researchers discovered an association between high fitness levels and low heart disease, even among those at genetic risk.
A minimally invasive heart valve replacement
A 58-year-old woman who survived Hodgkin’s lymphoma and lung cancer needed a new heart valve, but open-heart surgery was considered too risky. So her doctor suggested a minimally invasive approach.